Results 1 to 10 of about 214,432 (171)

Genotypic analysis of drug-resistant tuberculosis in Ghana: Insights into pre-XDR and XDR-TB. [PDF]

open access: yesPLoS ONE
BackgroundThe emergence of Extensively Drug Resistant (XDR) and Pre-extensively drug resistant (Pre-XDR) tuberculosis (TB) threatens the management of multidrug-resistant tuberculosis (MDR) patients and impacts negatively on TB control programs ...
Stephen Ofori Yirenkyi   +5 more
doaj   +3 more sources

Global trends in the incidence rates of MDR and XDR tuberculosis: Findings from the global burden of disease study 2019

open access: yesFrontiers in Pharmacology, 2023
Purpose: The study aimed to quantify the global trends of the incidence rates of multidrug-resistant (MDR) tuberculosis (MDR-TB) and extensively drug-resistant (XDR) tuberculosis (XDR-TB).Methods: Cases, age-standardized rates (ASRs), and incidence rates
Rong Qiang, Qingting Bu
exaly   +3 more sources

Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era [PDF]

open access: yesLung India, 2023
Background: Drug-resistant tuberculosis (DR-TB) is the most exigent and calamitous challenge encountered in treatment of TB. Extra pulmonary (EP) DR-TB poses a complex diagnostic and therapeutic challenge owing to myriad of presentations and ...
Ketaki V Utpat   +2 more
doaj   +2 more sources

Can Multidrug‐Resistant and Extensively Drug‐Resistant Tuberculosis be Treated More Successfully? [PDF]

open access: yesPublic Health Chall
Drug‐resistant cases of tuberculosis are increasing, complicating treatment strategies. Prior to the development of pharmacological agents, improving patient health at institutions called ‘sanatoria’ was a successful primary treatment. World Health Organization data combined with information from historical reports estimate that current treatments can ...
Holloway‐Kew K, Henneberg M.
europepmc   +2 more sources

Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019

open access: yesEmerging Infectious Diseases, 2022
Definitions of resistance in multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB) have been updated. Pre–XDR TB, defined as MDR TB with additional resistance to fluoroquinolones, and XDR TB, with additional ...
Yousra Kherabi   +7 more
doaj   +1 more source

Clusters of Drug-Resistant Mycobacterium tuberculosis Detected by Whole-Genome Sequence Analysis of Nationwide Sample, Thailand, 2014–2017

open access: yesEmerging Infectious Diseases, 2021
Multidrug-resistant tuberculosis (MDR TB), pre-extensively drug-resistant tuberculosis (pre-XDR TB), and extensively drug-resistant tuberculosis (XDR TB) complicate disease control.
Ditthawat Nonghanphithak   +12 more
doaj   +1 more source

Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa

open access: yesScientific Reports, 2022
Tuberculosis (TB) remains a leading infectious disease killer globally. Treatment outcomes are especially poor among people with extensively drug-resistant (XDR) TB, until recently defined as rifampicin-resistant (RR) TB with resistance to an ...
Karla Therese L. Sy   +9 more
doaj   +1 more source

Resistance patterns and trends of extensively drug-resistant tuberculosis: 5-year experience [PDF]

open access: yesJournal of Microbiology and Infectious Diseases, 2013
Objective: Extensively drug-resistant tuberculosis (XDR-TB) strains were emerged when multidrug-resistant TB (MDR-TB) was inadequately treated. Inadequate treatment of MDR-TB cases may result in additional resistance especially non-XDR-TB and then XDR-TB.
Amresh Kumar Singh   +6 more
doaj   +2 more sources

Evaluation of Sensitivity and Resistance of Linezolid in Pre Extensively Drug Resistance Tuberculosis and Extensively Drug Resistance Tuberculosis at a Tertiary Care Hospital, Jamnagar, Gujarat, India [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2019
Introduction: The diseases have a high prevalence in India, accounting for one fourth of the Tuberculosis (TB) cases in the world. The situation becomes more complicated due to the rising of Human Immunodeficiency virus/AIDS pandemic, the emergence of ...
Dipali Maganbhai Gavali   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy